Works matching IS 11753277 AND DT 2024 AND VI 24 AND IP 2


Results: 12
    1
    2
    3
    4

    Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea.

    Published in:
    American Journal of Cardiovascular Drugs, 2024, v. 24, n. 2, p. 313, doi. 10.1007/s40256-024-00632-w
    By:
    • Kim, Eui-Soon;
    • Park, Sun-Kyeong;
    • Cho, Daniel Sung-ho;
    • Youn, Jong-Chan;
    • Lee, Hye Sun;
    • Lee, Hae-Young;
    • Cho, Hyun-Jai;
    • Choi, Jin-Oh;
    • Jeon, Eun-Seok;
    • Lee, Sang Eun;
    • Kim, Min-Seok;
    • Kim, Jae-Joong;
    • Hwang, Kyung-Kuk;
    • Cho, Myeong-Chan;
    • Chae, Shung Chull;
    • Kang, Seok-Min;
    • Park, Jin Joo;
    • Choi, Dong-Ju;
    • Yoo, Byung-Su;
    • Cho, Jae Yeong
    Publication type:
    Article
    5
    6
    7
    8
    10
    11
    12